ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.473,63
1,32%
S&P 500
5.735,96
-0,16%
Dow Jones
42.332,37
0,37%
Euro vs US Dollar
1,11632
-0,11%
Bitcoin
65.620,01
0,67%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Provectus Biopharmaceuticals Inc (QB) (PVCT)

  7. Provectus Biopharmaceuticals Inc (QB) (PVCT) News

PVCT

Provectus Biopharmaceuti... (QB) (PVCT)

Provectus Biopharmaceuticals Inc (QB)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:PVCT
DatumZeitQuelleÜberschriftSymbolFirma
20/09/202423h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
30/08/202415h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
27/08/202417h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
19/08/202421h06Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
15/08/202401h23Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
15/08/202401h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
13/08/202419h21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
09/08/202421h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
05/08/202423h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
23/07/202423h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
22/07/202421h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
19/07/202419h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
17/07/202422h07Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
17/07/202421h50Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
20/06/202415h30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
20/06/202412h03Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
17/06/202423h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
28/05/202423h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
14/05/202420h43Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
13/05/202419h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
09/05/202416h54Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
06/05/202419h57Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
06/05/202419h56Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
29/02/202415h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
28/02/202421h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
28/02/202420h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
22/02/202415h30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
20/02/202417h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
16/02/202423h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
15/02/202414h05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
 Showing the most relevant articles for your search:USOTC:PVCT

Kürzlich von Ihnen besucht

NASDAQ
FAULNX
FT Top Themes ETF Model ...
LSE
35QQ
Lloyds Bk. 24
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten